Accendra Health (ACH) Equity Average (2009 - 2026)

Accendra Health (ACH) has 18 years of Equity Average data on file, last reported at -$462.9 million in Q1 2026.

• Equity Average for Q1 2026 came in at -$462.9 million, down 179.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$462.9 million (down 179.99% YoY), and the FY2025 annual result was $62.7 million, down 91.81% from the prior year.
• Equity Average eased to -$462.9 million in Q1 2026 per ACH's latest filing, from -$445.2 million in the prior quarter.
• Over five years, Equity Average peaked at $966.8 million in Q4 2022 and troughed at -$462.9 million in Q1 2026.
• A 5-year average of $612.3 million and a median of $898.9 million in 2024 frame the typical range for Equity Average.
• The sharpest annual moves came in 2022 and 2026: Equity Average advanced 25.88% in 2022, then slumped 179.99% in 2026.
• A 5-year view of Equity Average shows it stood at $966.8 million in 2022, then decreased by 5.24% to $916.1 million in 2023, then fell by 19.11% to $741.0 million in 2024, then plunged by 160.08% to -$445.2 million in 2025, then fell by 3.96% to -$462.9 million in 2026.
• Business Quant data shows ACH's Equity Average at -$462.9 million in Q1 2026, -$445.2 million in Q4 2025, and -$355.3 million in Q3 2025.